| abstract |
Disclosed are compounds of formula (I), and pharmaceutically acceptable salts thereof, wherein the variables G, L, A, W, E, R2, R3, R4, R5, RN , and RC Are as defined herein. These compounds interact to inhibit the activity of the enzyme β-secretase. Accordingly, these compounds are useful for treating Alzheimer's disease and other similar diseases. Also disclosed are pharmaceutical compositions and methods for treating these diseases. |